Jason Bloomberg speaks to pharma executives and industry observers who believe top drug companies could soon focus more of their efforts on creating electronic health platforms, collecting user data and to more precisely define disease risks and personalize prevention and treatment. While most contributors seem to agree that these platforms could support the sale of therapeutics, some also see this model as a radical break from the traditional drug business.
Read the entire article at http://www.bio-itworld.com/els/2014/8/18/could-pharma-companies-succeed-digital-health-market.html.SHARE THIS:
